myTomorrows Matches Patients to Clinical Trials Using AI Hosted in Europe
myTomorrows is a health tech platform that uses AI to match deidentified patient medical profiles against clinical trials and expanded access treatments not yet approved for public use. AI-based matching saves around 90 percent of the time compared to manual review by a medical professional, turning a two-hour task into about one minute. Because the platform processes health data, its large language models are hosted in Europe on AWS to comply with GDPR.
Overview
myTomorrows is a health tech platform that uses AI to match deidentified patient medical profiles against clinical trials and expanded access treatments not yet approved for public use. AI-based matching saves around 90 percent of the time compared to manual review by a medical professional, turning a two-hour task into about one minute. Because the platform processes health data, its large language models are hosted in Europe on AWS to comply with GDPR.
This entry has 14 published fields tied to exact passages in an immutable source capture.
Inspect the highlighted sourceThe challenge
myTomorrows was founded after Dr. Ronald Brus, CEO of a biotech company, struggled to get his father — diagnosed with lung cancer — access to a specific investigational drug, despite his industry expertise. More broadly, an estimated 300 million people worldwide are looking for treatments and about 10,000 treatments are looking for patients, with matching a patient's medical profile to relevant clinical trials or expanded access programs manually taking a medical professional around two hours.
The solution
myTomorrows runs a platform where doctors and patients globally can discover and request access to treatments not yet approved for public use, either in clinical trials or expanded access programs. A doctor fills in a deidentifiable medical profile of their patient, and AI matches that profile to relevant treatment options; patients can also search for clinical trials themselves. Because the company processes health data, its large language models are hosted in Europe on AWS to comply with GDPR, and it uses AWS cloud infrastructure for reliability, scalability and performance. The company plans to integrate AI agents in the near future for tasks such as plotting the regulatory pathway to get a particular drug to a patient.
Reported business value
AI-based matching saves around 90% of the time in matching a patient's medical profile to clinical trials — what would take a medical professional two hours takes about a minute using AI. The platform has matched 17,700 patients and onboarded 3,000 doctors across 135 countries; in one cited case, AI matching identified 12 possible treatment routes for a patient who otherwise had zero options within standard care.
Sources
Open any source and check the claim yourself — that is the point of the register.
This record was researched and written with AI assistance, and its claims were checked against the sources above. (EU AI Act art. 50 transparency notice.)
Other healthcare entries in the register.
Less paperwork, more time for people: Azure OpenAI at Landsberg Hospital
Klinikum Landsberg am Lech, a German acute-care hospital, deployed an AI language solution built on Azure OpenAI with partner Pexon Consulting that transcribes doctor-patient consultations in real time via tablet, recognizes medical terms, structures the content, and transfers it directly into the hospital information system.
Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research
Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.
Novo Nordisk· DenmarkAzure OpenAI Service · Azure Cosmos DB · Azure Kubernetes Service +2BAYADA Builds a Unified, AI-Ready Platform for Compassionate Care
BAYADA Home Health Care is consolidating three separate legacy data platforms (multiple practice management systems, an on-prem ODS, and Snowflake) and 65+ enterprise data sources into a single Databricks Lakehouse under its Data Modernization program, using medallion tiers, Lakeflow Jobs, Asset Bundles, and Unity Catalog governance. As part of the migration, BAYADA uses an LLM-powered code converter and Databricks Assistant to automate SQL and stored-procedure translation, and applies a machine learning-based data mastering accelerator to create golden Client, Payor, Candidate, and Referrer records. BAYADA reports roughly 30% better workload performance and cost efficiency versus its prior Snowflake environment, and is laying a governed foundation for AI agents supporting payroll validation, compliance monitoring, and operational insights, separately from its roadmap for AI-assisted chart review and risk prediction.
BAYADA Home Health CareDatabricks SQL · Lakeflow Jobs · Unity Catalog +1
Heidi Health fine-tunes NVIDIA Parakeet/Nemotron ASR, cutting clinical transcription latency 75% and costs 64%
Heidi Health, which processes 2.4 million clinical consultations weekly across 110 languages, fine-tuned the open NVIDIA Parakeet V2 speech recognition model on 1,500 hours of curated clinical audio using the NVIDIA NeMo framework and 8x H100 GPUs, replacing its closed-source vendor ASR. The in-house Nemotron-based ASR stack cut end-to-end transcription latency from about 3.0 seconds to 0.7 seconds (75%+ improvement), reduced word error rate from 13% to 9.4%, and cut operating costs by 64% by eliminating per-minute API pricing, while giving Heidi full ownership of model weights for data sovereignty.
Was this helpful?
Your feedback helps us improve our use case database